Verastem Oncology to Present at the Jefferies London Healthcare Conference
Verastem Oncology (NASDAQ: VSTM) announced its participation in the Jefferies London Healthcare Conference, with an on-demand presentation available starting November 18, 2021, at 8:00 a.m. GMT (3:00 a.m. ET). A webcast will be accessible via the company's investor website, and an archived version will be available for 30 days. Verastem is dedicated to developing new cancer therapies, focusing on small molecule drugs that inhibit key signaling pathways critical for tumor growth and cell survival.
- None.
- None.
A webcast of the presentation will be available on investors section of the Company’s website at www.verastem.com. An archived presentation will be made available for 30 days.
About Verastem Oncology
View source version on businesswire.com: https://www.businesswire.com/news/home/20211111005376/en/
Investors:
Vice President, Corporate Development
+1 781-469-1579
amunshi@verastem.com
+1 212-600-1902
sherri@argotpartners.com
Media:
Corporate Communications
+1 781-292-4205
lbuffington@verastem.com
Source: Verastem Oncology
FAQ
What is Verastem Oncology's stock symbol?
When will Verastem's presentation at the Jefferies London Healthcare Conference be available?
Where can I watch Verastem's presentation?
How long will Verastem's presentation be available for viewing?